lapatinib + metronomic capecitabine for her2+ IBC--a case report

[Lani]

Ann Oncol. 2009 Dec 23. [Epub ahead of print]
Lapatinib and metronomic capecitabine combination in an HER2-positive inflammatory breast cancer patient: a case report.
Montagna E, Cancello G, Torrisi R, Rizzo S, Scarano E, Colleoni M.

Department of Medicine, Research Unit in Medical Senology.
PMID: 20032127

[Ellie F]

Hi Lani
Is there a link? really interested in this piece of info. My new onc originally suggested metronomic capecitabine but without lapatinib as it's not available here. Would really like to show him this case report
Thanks Ellie

[Jackie07]

Ellie,

Researchers in UK were already on it back in 2006:

http://www.cancer.org/downloads/STT/BCFF-Final.pdf

Hopefully Lani will be able to get a link to the new case report soon.

ps. Here's an abstract:

http://annonc.oxfordjournals.org/cgi/content/abstract/20/6/1026

with the purchase option:

<TABLE border=0 cellSpacing=0 cellPadding=0 width=445><TBODY><TR><TD width=415>Pay per View - If you would like to purchase short-term access you must have a personal account. Please sign in with your personal user name and password or register (http://www.oxfordjournals.org/jnls/register/userdetailsadduser.html?URL=http%3A%2F%2Fannonc.ox fordjournals.org%2Fcgi%2Fcontent%2Ffull%2Fmdp563v1 ) to obtain a user name and password for free. You may access this article for <!--ppacat--><NOBR>1 day for US$36.00</NOBR>. </TD></TR><TR><TD height=12 width=20>http://annonc.oxfordjournals.org/icons/spacer.gif</TD><TD height=12 vAlign=top width=10 align=middle>http://annonc.oxfordjournals.org/icons/spacer.gif</TD><TD height=12 width=415>http://annonc.oxfordjournals.org/icons/spacer.gif</TD></TR></TBODY></TABLE>

[Ellie F]

Thanks Jackie
Metronomic therapy seems to be gaining popularity at present.Let's hope we see some more breakthroughs this year
Ellie